Adsorbi develops a novel biomaterial based on cellulose, designed to capture gaseous air pollutants. Its application spans active airflow systems like gas filters in air filtration systems and air purifiers, as well as passive airflow applications such as packaging for sensitive goods.
BeammWave AB is a Swedish company based in Lund that specializes in the manufacture of radio frequency integrated chips, specifically designed for digital beamforming applications. Founded in 2016, BeammWave develops a single chip that integrates front-end components and antenna arrays, catering to mobile phones and Internet of Things (IoT) devices. The company's technology operates in the millimeter-wave spectrum, supporting 5G and future wireless communication standards. Through its innovative solutions, BeammWave aims to enhance connectivity and performance in modern communication devices.
Saab Ventures, established in 2001, is the corporate venture capital arm of Saab AB, headquartered in Stockholm, Sweden. It invests in technology companies, with a focus on those rooted in the defense, civil security, aviation, and space sectors. The firm makes both direct investments in startups and early-stage companies, as well as fund-of-fund investments in venture capital funds. Saab Ventures typically invests between SEK0.1 million and SEK50 million, seeking companies with an enterprise value between SEK40 million and SEK100 million within five years, and existing or potential revenues of SEK100 million within the same period. It prefers minority equity positions and co-investment opportunities, with an investment horizon of four to seven years.
Flox combines Generative AI and wildlife science to develop autonomous solutions for monitoring, detecting, and managing interactions between humans and wild animals. Utilizing advanced AI and drones, Flox aims to enhance human-wildlife coexistence by minimizing losses in agriculture and improving safety.
Blue Cromos Management Group
Grant in 2023
Blue Cromos Management Group specializes in providing comprehensive business analysis and optimization services. The company focuses on operational analysis, process management, and the development of key performance indicators (KPIs) to enhance organizational efficiency. By leveraging advanced business analytics and business intelligence techniques, Blue Cromos helps clients understand their goals and improve their operational excellence. This enables organizations to make informed decisions that optimize return on investment and align with both short-term and long-term objectives. Through its expertise, Blue Cromos Management Group aims to support businesses in achieving greater success and sustainability in their operations.
Net Zero Build
Grant in 2023
Net Zero Build is a technology company that provides an AI-driven platform to simplify and automate the process of obtaining sustainable building certifications for real estate projects. The platform helps project teams navigate certification requirements efficiently, collaborate with stakeholders, and reduce administrative costs. By empowering the real estate industry with digital tools, Net Zero Build aims to increase positive environmental impact and contribute to global climate change mitigation efforts, ultimately driving progress towards a net-zero emissions future in the real estate and construction sector.
Beat Vascular Health
Grant in 2023
Beat Vascular Health are revolutionizing cardiovascular diagnostics through non-invasive sensors. advanced signal processing and digital twin-modelling. We aim to enhance early detection and precise localization of cardiovascular diseases (CVD), initially Peripheral Arterial Disease (PAD), one of the most common CVDs.
Enerpoly is a pioneering energy storage technology company specializing in rechargeable zinc-ion battery chemistry. Its mission is to make clean energy accessible by developing safe, affordable, and sustainable battery solutions suitable for various applications.
XNK Therapeutics
Grant in 2023
XNK Therapeutics is a clinical-stage biotechnology company based in Stockholm, Sweden, specializing in immunotherapy for cancer prevention and treatment. The company is focused on developing innovative autologous natural killer (NK) cell-based therapies using its proprietary technology platform. XNK Therapeutics has positioned itself as a leader in the clinical development and manufacture of these therapies, which are designed to effectively target cancers, particularly in scenarios where allogeneic cell products may not be suitable. By harnessing the unique properties of its investigational drug candidates, XNK Therapeutics aims to play a crucial role in advancing cancer treatment strategies.
Beat Vascular Health
Grant in 2023
Beat Vascular Health are revolutionizing cardiovascular diagnostics through non-invasive sensors. advanced signal processing and digital twin-modelling. We aim to enhance early detection and precise localization of cardiovascular diseases (CVD), initially Peripheral Arterial Disease (PAD), one of the most common CVDs.
Ecohelix harnesses underutilized lignocellulosic side streams from the pulp industry into valuable, sustainable products. Utilizing a patented enzymatic process, Ecohelix converts residual lignin and hemicellulose into WOODMER®, a biodegradable polymer used in packaging, adhesives, and paper chemicals.
Qlucore is a prominent provider of advanced bioinformatics software designed for research and precision diagnostics in the life sciences. Founded in 2007 by researchers from Lund University in Sweden, the company aims to simplify the analysis of complex data generated in the fields of genetics and proteomics. Its flagship product, Qlucore Omics Explorer, is a user-friendly bioinformatics tool that enables researchers, technicians, and physicians to easily interpret and visualize large datasets. Additionally, Qlucore offers Qlucore Diagnostics, an AI-powered platform for multi-omics companion and precision diagnostics that integrates with various data-generating instruments. With a global presence, Qlucore serves customers in approximately 35 countries, including leading pharmaceutical companies, hospitals, and academic institutions.
Intervacc is a biotechnology company that specializes in the development of vaccines utilizing recombinant proteins for animal health care. The company addresses the growing demand for effective vaccines by creating innovative solutions tailored to this sector. In addition to its vaccine development, Intervacc, through its subsidiary, is engaged in diagnostics within the Swedish animal health market, providing comprehensive bacteriological and mycological analyses. Through these efforts, Intervacc aims to enhance animal health and contribute to the overall well-being of veterinary care.
Johannas Stadsodlingar
Grant in 2023
Johannas Stadsodlingar produces fish, vegetables and herbs through a sustainable aquaponics system that circulates water and nutrients between fish and plants, reducing environmental impact and water use. The company is based in Stockholm, Sweden.
Invivopower is a company specializing in transcutaneous wireless energy transfer technology aimed at improving the quality of life and extending the lifespan of patients with heart failure. The firm develops innovative energy-linked solutions that facilitate the operation of active medical implants, such as artificial hearts, ventricular assist devices, neural stimulators, retinal implants, cochlear implants, and insulin pumps. Its technology features a connector that acts as the primary winding in a transformer, allowing it to be attached to the body without compromising the skin. This advancement offers a significant breakthrough for manufacturers of medical devices by enhancing patient care and treatment outcomes.
Flox combines Generative AI and wildlife science to develop autonomous solutions for monitoring, detecting, and managing interactions between humans and wild animals. Utilizing advanced AI and drones, Flox aims to enhance human-wildlife coexistence by minimizing losses in agriculture and improving safety.
Oncopeptides
Grant in 2023
Oncopeptides is a biotechnology company focused on developing therapies for difficult-to-treat hematological diseases. It leverages a proprietary Peptide Drug Conjugate platform to design compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. The lead program, melflufen (Pepaxti), is a peptide-conjugated alkylator that belongs to a class called Peptidase Enhanced Compounds. The approach aims to improve targeting to malignant cells while minimizing exposure to healthy tissue. The company concentrates on hematologic cancers, with an emphasis on multiple myeloma, and pursues research, development, and commercialization efforts.
Enerpoly is a pioneering energy storage technology company specializing in rechargeable zinc-ion battery chemistry. Its mission is to make clean energy accessible by developing safe, affordable, and sustainable battery solutions suitable for various applications.
Johannas Stadsodlingar
Grant in 2023
Johannas Stadsodlingar produces fish, vegetables and herbs through a sustainable aquaponics system that circulates water and nutrients between fish and plants, reducing environmental impact and water use. The company is based in Stockholm, Sweden.
Mycorena AB, founded in 2017 and based in Gothenburg, Sweden, specializes in the development of nutritious fungi-based protein. The company aims to provide a sustainable alternative to both meat and traditional plant-based proteins, leveraging fungi biotechnology to create vegan protein solutions that use significantly fewer resources. Mycorena addresses global sustainability challenges by promoting a circular economy through its innovative food manufacturing processes. Its products enable customers to make environmentally conscious choices while contributing to a more sustainable food system.
Johannas Stadsodlingar
Grant in 2022
Johannas Stadsodlingar produces fish, vegetables and herbs through a sustainable aquaponics system that circulates water and nutrients between fish and plants, reducing environmental impact and water use. The company is based in Stockholm, Sweden.
Mentice specializes in virtual reality-based medical simulation solutions for healthcare professionals. Their offerings cover neurovascular, cardiovascular, and peripheral interventions, aiming to enhance skills acquisition, continuous development, and pre-procedural planning. Mentice's scientifically validated solutions are designed specifically for the medical industry.
Pirr is revolutionizing storytelling with AI. We are focused on the worlds largest literary genre - romance, estimated to reach usd 28bn in sales by 2030. Users can create all types of romance stories - historical, romantasy, contemporary, spicy stories and much more. Users can share stories and create with others. We have reached 360 thousand organic downloads and average an average session time of almost 30 minutes per user.
Oncopeptides
Grant in 2022
Oncopeptides is a biotechnology company focused on developing therapies for difficult-to-treat hematological diseases. It leverages a proprietary Peptide Drug Conjugate platform to design compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. The lead program, melflufen (Pepaxti), is a peptide-conjugated alkylator that belongs to a class called Peptidase Enhanced Compounds. The approach aims to improve targeting to malignant cells while minimizing exposure to healthy tissue. The company concentrates on hematologic cancers, with an emphasis on multiple myeloma, and pursues research, development, and commercialization efforts.
Compular specializes in the development of advanced analytic tools for high-tech materials. The company focuses on providing simulation and analysis capabilities that predict material properties based on intuitive design principles. Their tools deliver actionable insights into the properties of materials and liquids, facilitating the screening of candidate formulations and predicting parameters for continuum scale simulations. By employing finely tuned molecular dynamics and density functional theory, Compular enhances mechanistic understanding of material functions. Their applications span various industries, including batteries, fuel cells, metals and alloys, pharmaceuticals, electronics, and chemicals, ultimately enabling clients to adopt a predictive approach in their R&D processes and improve the success rate of laboratory trials.
Pirr
Pre Seed Round in 2022
Pirr is revolutionizing storytelling with AI. We are focused on the worlds largest literary genre - romance, estimated to reach usd 28bn in sales by 2030. Users can create all types of romance stories - historical, romantasy, contemporary, spicy stories and much more. Users can share stories and create with others. We have reached 360 thousand organic downloads and average an average session time of almost 30 minutes per user.
Neue is an open innovation organization focused on fostering digital technology innovation and entrepreneurial talent to drive economic growth and enhance quality of life. The company is dedicated to lowering the barrier from prototyping to industrialization for connected products, particularly in the Internet of Things (IoT) sector. With its Neue Playground platform, it offers a versatile and accessible environment for developers, designers, and innovators. This low-code, end-to-end solution enables users to transition swiftly from idea to prototype to finished product. By generating firmware and building cloud functions and web applications within a single tool, Neue Playground streamlines the development process. The platform also incorporates artificial intelligence to assist users at every stage, making it an essential resource for those looking to create and scale connected products efficiently.
Elicera Therapeutics
Grant in 2022
Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.
AirForestry innovates forest management by thinning forests from the air using electric drones. This method reduces carbon emissions from traditional forestry work while increasing a forest's carbon sequestration capacity by freeing up land previously used for access roads.
We are building a decentralized language education platform that allows students and teachers to build personalized and comprehensive learning experiences in record speed.
Royal Schedule
Grant in 2021
Royal Schedule develops a cloud-based scheduler that automates complex scheduling processes for professionals such as teachers and nurses. Its platform uses smart algorithms to generate multiple schedules quickly, managing rules and conditions efficiently.
Compular specializes in the development of advanced analytic tools for high-tech materials. The company focuses on providing simulation and analysis capabilities that predict material properties based on intuitive design principles. Their tools deliver actionable insights into the properties of materials and liquids, facilitating the screening of candidate formulations and predicting parameters for continuum scale simulations. By employing finely tuned molecular dynamics and density functional theory, Compular enhances mechanistic understanding of material functions. Their applications span various industries, including batteries, fuel cells, metals and alloys, pharmaceuticals, electronics, and chemicals, ultimately enabling clients to adopt a predictive approach in their R&D processes and improve the success rate of laboratory trials.
Compular specializes in the development of advanced analytic tools for high-tech materials. The company focuses on providing simulation and analysis capabilities that predict material properties based on intuitive design principles. Their tools deliver actionable insights into the properties of materials and liquids, facilitating the screening of candidate formulations and predicting parameters for continuum scale simulations. By employing finely tuned molecular dynamics and density functional theory, Compular enhances mechanistic understanding of material functions. Their applications span various industries, including batteries, fuel cells, metals and alloys, pharmaceuticals, electronics, and chemicals, ultimately enabling clients to adopt a predictive approach in their R&D processes and improve the success rate of laboratory trials.
Johannas Stadsodlingar
Grant in 2020
Johannas Stadsodlingar produces fish, vegetables and herbs through a sustainable aquaponics system that circulates water and nutrients between fish and plants, reducing environmental impact and water use. The company is based in Stockholm, Sweden.
DBtune specializes in optimizing database performance. It offers a platform that tunes databases in cloud or on-premises environments using machine learning and AI. The platform tailors optimizations to specific customer workloads and hardware, reducing load on underlying systems.
We are on a mission to empower everyone to take action for a more sustainable and responsible world.
We created EveryAct, an internal social platform that boosts employee engagement, amplifies internal CSR communications, and improves company’s overall influence and growth.
InDex Pharmaceuticals
Grant in 2020
InDex Pharmaceuticals AB, founded in 2016 and based in Stockholm, Sweden, is a clinical-stage biopharmaceutical company focused on developing innovative treatments for immunological diseases. Its flagship product, cobitolimod, is designed to provide local anti-inflammatory effects, healing mucosa and improving clinical symptoms in patients with ulcerative colitis. The company's platform technology involves DNA-based ImmunoModulatory Sequences (DIMS), which are used to treat a variety of immunological diseases. Additionally, InDex Pharmaceuticals offers DiBiCol, a diagnostic kit that monitors biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy.
TEXEL Energy Storage
Grant in 2020
TEXEL Energy Storage is a battery technology development company focused on creating cost-effective energy storage solutions that can compete with fossil fuels. The company specializes in developing a hybrid energy storage platform designed to store energy from concentrated solar power (CSP) and integrates with renewable energy technologies. By moving beyond traditional lithium-based systems, TEXEL aims to provide viable electricity storage that is not only economical but also recyclable, contributing to a sustainable energy future.
Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.
STILFOLD innovates high-value industries through its proprietary Origami Folding Technology. Powered by machine learning and origami engineering, STILFOLD enables faster production of lighter, stronger, and more efficient products with reduced material usage and carbon emissions.
Jaisy Health
Grant in 2019
Jaisy Health is a company based in Stockholm, Sweden, that specializes in developing jaundice detection equipment aimed at providing a low-cost and highly accurate solution for non-invasive jaundice assessment in infants. Founded in 2018, Jaisy Health utilizes advanced technology to create an optical mobile device that connects to smartphones. This device measures bilirubin levels and predicts the risk of jaundice, enabling timely and accessible detection regardless of location or time. By focusing on affordability and accuracy, Jaisy Health offers an innovative approach to managing jaundice in newborns.
Redsense Medical
Grant in 2019
Redsense Medical AB, founded in 2000 and headquartered in Halmstad, Sweden, specializes in developing and marketing safety systems for medical treatments, primarily focusing on the dialysis sector in Europe and the United States. The company's flagship product, the Redsense System, utilizes patented fiber optic sensors to detect blood leakage during hemodialysis, triggering visual and audible alarms to alert caregivers and patients. In addition to the alarm system, Redsense Medical is developing the Redsense Clamp, an accessory designed to automatically stop blood flow by clamping the blood line upon detection of an issue. With a commitment to enhancing patient safety, the company provides innovative solutions tailored to the needs of healthcare providers in the dialysis industry.
Nomadic Retail
Seed Round in 2019
xNomad is a marketplace that facilitates the connection between brands and short-term retail spaces, specializing in pop-up store experiences. The company provides an innovative online platform that allows brands to quickly and efficiently identify and secure vacant retail spaces worldwide. In addition to space rental, xNomad offers a comprehensive suite of services, including design, furniture, and staffing solutions, which simplifies the process of launching pop-up stores. Utilizing data on foot traffic, demographics, and customer engagement, xNomad helps brands make informed decisions about store locations and measure their success. This streamlined approach enables brands and e-commerce businesses to create impactful retail experiences with ease.
Vycellix, Inc. is a privately held company focused on advancing immunotherapy through innovative cell and gene-based therapies. The company is dedicated to addressing the challenges associated with existing therapies by developing proprietary approaches that optimize and enhance cell-based immunotherapeutic products. By leveraging novel platforms, Vycellix aims to improve patient outcomes and overcome the limitations of current treatment methodologies.
Mendi
Venture Round in 2019
Mendi is a company based in Stockholm, Sweden, that specializes in developing an at-home neurofeedback brain training headband and accompanying mobile application. Founded in 2018, Mendi's innovative hardware device aims to enhance mental well-being by improving focus, emotional regulation, and mental resilience. The headband can be used in conjunction with the app to facilitate mental training, allowing users to engage in brain-strengthening exercises with no usage limits. Through this technology, Mendi seeks to empower individuals to enhance their overall mental health and performance.
Price Edge is developing the dream pricing software - a cloud based price management tool for enterprises, that give them access to new pricing strategies and more flexibility than ever before.
Price Edge is working with many of the largest brands in the world and we have recently started to ramp up our global growth. We are a young, energetic team pursuing the vision of building a global B2B SaaS company that will fundamentally change the way enterprises work with pricing.
Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.
Royal Schedule
Grant in 2019
Royal Schedule develops a cloud-based scheduler that automates complex scheduling processes for professionals such as teachers and nurses. Its platform uses smart algorithms to generate multiple schedules quickly, managing rules and conditions efficiently.
Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.
Yolean AB is a Swedish company based in Gothenburg that specializes in developing visual management tools aimed at facilitating digital Lean transformations. The company provides software solutions that integrate wall-based visual management techniques with backend data management, allowing project and knowledge managers to enhance visibility and transparency in knowledge work. Yolean's offerings include visual planning tools, pulse solutions, and check sheets, which support real-time collaboration across teams and help identify bottlenecks in workflow. By serving clients in sectors such as automotive and public services, Yolean focuses on improving team synchronization and project management through effective visual collaboration and continuous data-driven improvements.
TrusTrace is a software company based in Stockholm, Sweden, with an additional location in Coimbatore, India, that specializes in traceability as a service for the fashion supply chain. Founded in 2016, TrusTrace offers a comprehensive platform that enables global brands and suppliers to capture, digitize, and share supply chain and material traceability data efficiently. Its suite of tools includes T-Tracem for end-to-end product traceability, T-CET for customer engagement, I-CAT for climate action management, and T-VeM for vendor management, among others. The platform consolidates validated supply chain data, allowing brands to substantiate product claims and ensure regulatory compliance while managing their environmental impact. By providing a single platform for traceability, TrusTrace empowers brands to enhance transparency and trust in their supply chains.
Grönska is a young, Swedish tech-company that develops technology for vertical farming, and grows and sells vegetables and herbs. Vertical farming that is based on the use of LED lighting and hydroponic watering systems. This method allows us to grow food indoors, locally and all year round. The reason we do this is to offer a sustainable, locally grown alternative to imported food and to enable more self-sufficient cities.
Grönska was founded in 2014 and constructed the largest vertical farm in the Nordics in 2018.
Johannas Stadsodlingar
Grant in 2018
Johannas Stadsodlingar produces fish, vegetables and herbs through a sustainable aquaponics system that circulates water and nutrients between fish and plants, reducing environmental impact and water use. The company is based in Stockholm, Sweden.
Bintel AB is a Swedish company founded in 2018 and based in Helsingborg that specializes in developing and marketing innovative sensors for waste management. Its primary product is a digital waste-management platform that includes sensors mounted on household waste bins. These sensors notify waste collectors when bins are full and communicate with route planning tools to optimize collection routes. This technology is designed to assist recycling companies, real estate firms, and municipalities in reducing waste collection costs and improving overall efficiency in waste management.
DeviceRadio AB is a Swedish company based in Malmö, founded in 2016, that focuses on creating a communication layer designed to facilitate data transfer across various devices and connectivity methods in the Internet of Things (IoT) sector. The company's innovative solution allows seamless communication between devices using different technologies, including Bluetooth, broadband cellular networks, WiFi, and SMS. By addressing the complexity and fragmentation in the IoT landscape, DeviceRadio aims to provide a unified infrastructure that enables developers to integrate and utilize IoT capabilities more effectively. This approach not only enhances operational efficiency but also supports the development of diverse applications, such as improving emergency response times and agricultural productivity, thereby contributing to a more connected and efficient future.
Spago Nanomedical
Grant in 2018
Spago Nanomedical specializes in nanomedicine research and development, focusing on cancer diagnostics and treatment. Its key products include SpagoPix, a tumor-selective contrast agent for magnetic resonance imaging, and Tumorad, a radionuclide therapy for targeted radiation of cancerous tumors.
Enerpoly is a pioneering energy storage technology company specializing in rechargeable zinc-ion battery chemistry. Its mission is to make clean energy accessible by developing safe, affordable, and sustainable battery solutions suitable for various applications.
Imagimob
Venture Round in 2017
Imagimob AB is a Stockholm-based company specializing in artificial intelligence products focused on movement analytics for both objects and people. The company has developed SensorBeat, a comprehensive motion intelligence system that integrates hardware and software components, including sensors, storage, Bluetooth low energy capabilities, and communication ports. SensorBeat is designed for real-time artificial intelligence processing at the edge, allowing for applications such as audio classification, gesture recognition, predictive maintenance, fall detection, and material detection. This platform enables companies to efficiently create and deploy AI applications for embedded devices, enhancing their functionality and responsiveness.
Deedster
Venture Round in 2017
Deedster is a digital platform focused on promoting sustainable consumption. It allows users to track their carbon footprint resulting from everyday activities, providing insights that encourage more environmentally friendly choices. The platform fosters a community where individuals can challenge themselves and others to adopt sustainable practices, ultimately aiming to lead a collective shift towards a more sustainable lifestyle. By leveraging technology, Deedster empowers users to understand the impact of their consumption habits and make informed decisions for a greener future.
Beactica Therapeutics
Grant in 2017
Beactica Therapeutics specializes in precision oncology, focusing on developing novel small molecule therapeutics for genetically defined cancers with significant unmet clinical need. The company employs a molecular interaction-based drug discovery engine to generate innovative treatments, including allosteric modulators and targeted protein degraders (PROTACs). Beactica aims to deliver value to patients and shareholders by advancing its programs into early clinical trials.
MetaboGen is a research and development company focused on biomarker and personalized treatment services. It specializes in integrating metagenomic data analysis with clinical programs, aiming to develop innovative therapeutics and next-generation probiotics. The company identifies and enhances bacterial strains related to specific indications, which supports the probiotic industry in creating novel diagnostic tests and treatments. Through its expertise in metagenomics, MetaboGen contributes to advancements in personalized medicine and the development of effective probiotic solutions.
TrusTrace is a software company based in Stockholm, Sweden, with an additional location in Coimbatore, India, that specializes in traceability as a service for the fashion supply chain. Founded in 2016, TrusTrace offers a comprehensive platform that enables global brands and suppliers to capture, digitize, and share supply chain and material traceability data efficiently. Its suite of tools includes T-Tracem for end-to-end product traceability, T-CET for customer engagement, I-CAT for climate action management, and T-VeM for vendor management, among others. The platform consolidates validated supply chain data, allowing brands to substantiate product claims and ensure regulatory compliance while managing their environmental impact. By providing a single platform for traceability, TrusTrace empowers brands to enhance transparency and trust in their supply chains.
DeviceRadio AB is a Swedish company based in Malmö, founded in 2016, that focuses on creating a communication layer designed to facilitate data transfer across various devices and connectivity methods in the Internet of Things (IoT) sector. The company's innovative solution allows seamless communication between devices using different technologies, including Bluetooth, broadband cellular networks, WiFi, and SMS. By addressing the complexity and fragmentation in the IoT landscape, DeviceRadio aims to provide a unified infrastructure that enables developers to integrate and utilize IoT capabilities more effectively. This approach not only enhances operational efficiency but also supports the development of diverse applications, such as improving emergency response times and agricultural productivity, thereby contributing to a more connected and efficient future.
Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.
Mimerse
Funding Round in 2017
Mimerse, founded in 2014, specializes in developing evidence-based psychological treatments utilizing immersive technologies, particularly virtual reality. The company collaborates with leading universities and hospitals to create applications aimed at clinicians and researchers. Notably, Mimerse is recognized for being the first organization to clinically validate an automatic virtual reality treatment for specific phobias. Its platform is designed to enhance mental wellness by providing innovative solutions for professionals and consumers alike, enabling effective management and treatment of various mental health conditions.
Ximantis aims for Smart/Green and Integrated transport by demonstrating a revolutionary road traffic prediction method based on collecting and analyzing “big data” in order to greatly reduce CO2 emissions, decrease overall congestion impact and optimize navigation - the equivalent of a weather forecast for traffic flow and congestion!
In addition, Ximantis innovates on advanced vehicle software systems for Connected Cars and Autonomous Navigation through their deep learning Stochastic Re-construction Module, offering safe reaction and anticipation to eminent risk.
MyVox is a technology company that develops a human-machine interface platform based on 3D ultrasound. Its team includes experienced engineers and serial entrepreneurs who pursue deep-tech innovation to create disruptive ultrasound solutions. The platform leverages MEMS-based speaker technology, using piezoelectric and silicon membranes to emit ultrasound under an AC field, enabling more intuitive interaction between users and electronic devices.
Rightprice.ai
Grant in 2017
RightPrice AI is a Stockholm-based company specializing in e-commerce pricing through the use of artificial intelligence and deep learning. The company has developed a sophisticated price optimization platform that processes data from web-based scripts and price crawlers. Utilizing proprietary machine learning algorithms, RightPrice AI analyzes web traffic, sales figures, and competitor pricing to provide businesses with actionable pricing recommendations. This enables clients to maximize their profit margins by predicting optimal price points based on comprehensive analysis of visitor behavior and product data.
First Derm (iDoc24 Inc)
Grant in 2017
First Derm is iDoc24 Inc product, that has been developed from 4 years of scientific medical research. It allows anyone (B2C, B2B2C and B2B) to anonymously submit images of skin/hair/nail concerns directly to a vetted board certified dermatologist and within hours receive an on what it is and what to do next.
We have users in 160 countries and in 7 languages. To date we have found over 500 skin cancer lesions, 1000s of STDs and general skin/hair/nail concerns.
Available on iOS, Android, and web.
Ximantis aims for Smart/Green and Integrated transport by demonstrating a revolutionary road traffic prediction method based on collecting and analyzing “big data” in order to greatly reduce CO2 emissions, decrease overall congestion impact and optimize navigation - the equivalent of a weather forecast for traffic flow and congestion!
In addition, Ximantis innovates on advanced vehicle software systems for Connected Cars and Autonomous Navigation through their deep learning Stochastic Re-construction Module, offering safe reaction and anticipation to eminent risk.
Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.
InDex Pharmaceuticals
Grant in 2016
InDex Pharmaceuticals AB, founded in 2016 and based in Stockholm, Sweden, is a clinical-stage biopharmaceutical company focused on developing innovative treatments for immunological diseases. Its flagship product, cobitolimod, is designed to provide local anti-inflammatory effects, healing mucosa and improving clinical symptoms in patients with ulcerative colitis. The company's platform technology involves DNA-based ImmunoModulatory Sequences (DIMS), which are used to treat a variety of immunological diseases. Additionally, InDex Pharmaceuticals offers DiBiCol, a diagnostic kit that monitors biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy.
Fundler
Seed Round in 2016
Fundler AB, established in Stockholm, Sweden in 2015, operates an automated investment platform for private investors. The company, previously known as Primepilot AB, offers a robo-advisory service that tailors portfolios of funds and exchange-traded funds based on clients' investment horizons, financial situations, risk profiles, goals, knowledge, and experience. Through its app, Fundler enables users to place orders for purchases or sales, facilitating the management of their savings portfolios automatically.
Winfoor has developed Triblade, a new and groundbreaking technology for large scale wind turbine rotor blades, that can disrupt the entire wind power industry. The patent pending technology is a 3-in-1-blade that will reduce production cost and transport cost dramatically, while allowing rotor blades to be longer, stronger and much lighter than what is possible today.
These are game changing improvements that gives Winfoor a unique opportunity in today’s global wind turbine rotor blade market. The technology can also play a decisive role in the development of next generation of larger, more powerful wind turbines and to accelerate the transition to greater use of renewables worldwide.
Bokio
Pre Seed Round in 2015
Bokio AB, founded in 2015 and based in Gothenburg, Sweden, specializes in developing and marketing accounting software that leverages artificial intelligence. The company provides solutions for bookkeeping, invoicing, and payroll services, making accounting accessible to small business owners, particularly in the UK. Its platform automates various financial processes, allowing users to efficiently manage their finances in one place. Additionally, Bokio serves as a marketplace for supplementary services that assist small business owners in simplifying their operations, including finding optimal insurance and pension solutions. The company also collaborates with partners to offer services like invoice sales to enhance liquidity and facilitates the sending of payslips and invoices through conventional mail, encompassing printing, envelopes, and postage.
Beactica Therapeutics
Grant in 2014
Beactica Therapeutics specializes in precision oncology, focusing on developing novel small molecule therapeutics for genetically defined cancers with significant unmet clinical need. The company employs a molecular interaction-based drug discovery engine to generate innovative treatments, including allosteric modulators and targeted protein degraders (PROTACs). Beactica aims to deliver value to patients and shareholders by advancing its programs into early clinical trials.
VBN Components
Venture Round in 2013
VBN Components AB is a Swedish manufacturer specializing in 3D printed metal parts using its proprietary Vibenite® alloys. These parts are renowned for their exceptional wear and heat resistance, making them ideal for industrial applications. The company's patented free molding technology allows for the creation of complex, free-form components with reduced material waste and faster production times, eliminating the need for traditional metal cutting processes. VBN Components' innovative approach enables manufacturers to enhance the performance of their end products through improved geometry and increased wear resistance.
Saplo develops an automatic text analytics platform that uses semantic technologies to mimic how humans read and evaluate text. The platform extracts and refines information from large text collections through services such as entity tagging, topic tagging, related and similar article identification, contextual recognition, and sentiment analysis. It can automatically identify companies, people, and locations, match topics even when not explicitly mentioned, measure semantic similarity between documents, define and match custom textual contexts, and evaluate emotions expressed by writers. Saplo delivers reports for the public, custom solutions for clients, and an API for developers. The company participated in Seedcamp Week 2008.
Beactica Therapeutics
Grant in 2007
Beactica Therapeutics specializes in precision oncology, focusing on developing novel small molecule therapeutics for genetically defined cancers with significant unmet clinical need. The company employs a molecular interaction-based drug discovery engine to generate innovative treatments, including allosteric modulators and targeted protein degraders (PROTACs). Beactica aims to deliver value to patients and shareholders by advancing its programs into early clinical trials.